Editor's Note Research shows antibiotic-resistant infections could lead to 8.2 million deaths annually by 2050, representing a 75% increase from current rates, according to a September 17 article in HealthDay. Published in the Lancet, the new study highlights the growing threat of growing threat of antimicrobial resistance (AMR), predicting that…

Read More

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

Editor's Note The common practice of administering potassium after bypass surgery can be safely abandoned in patients with normal blood levels, according to results of the randomized TIGHT-K trial. According to a September 3 report in Medscape, potassium supplementation is a widely accepted means of reducing the risk of postoperative…

Read More

Editor's Note Research reveals nearly 10% of patients treated with prescription opioid painkillers develop opioid dependency or opioid use disorder (OUD), Healio reported on August 13. Additionally, nearly 30% of patients exhibit signs and symptoms indicating potential OUD. Originally published in the journal Addiction, the data are from a systematic…

Read More

Editor's Note A shuttered bariatric surgery center in Oklahoma last month is just one example of how the rise of Glucagon-like peptide-1 (GLP-1) agonists are reshaping health systems’ investments, Axios reported August 13. Rather than “massive hospital towers with cardiology clinics, dialysis beds and joint replacement centers,” the focus is…

Read More

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

Editor's Note Propofol research published in the journal Neuron has broader implications for enabling more precise, safer doses of anesthesia, according to an August 14 report in Anesthesiology News. According to the article, anesthesiologists tend to use higher doses of anesthetics because they rely on indirect measures, such as heart…

Read More

Editor's Note Medicare’s first negotiations on 10 top-selling prescription drugs for older Americans will save the US government $6 billion in the first year, according to an August 15 article in Reuters. Enabled by President Joe Biden’s 2022 Inflation Reduction Act, negotiations for drugs used by Medicare—which covers 66 million…

Read More

Editor's Note For diabetic patients with obesity and chronic kidney disease (CKD), metabolic bariatric surgery could protect the kidneys better than therapy with glucagon-like peptide-1 receptor agonists (GLP-1RA), according to research published in the September issue of the Annals of Surgery. Conducted at a large US health system, the study…

Read More

Editor's Note Many youths continue to take opioids months after undergoing surgery, according to a recent multi-institutional study published in JAMA Network. Medical Xpress covered the news July 11. Conducted by researchers from CHOP, Massachusetts General Hospital, University of Pennsylvania, and Stanford Medicine, the study found 1 in 6 youths…

Read More